20 years of Cure Parkinson's
We’re here for the cure! This year marks 20 years since Cure Parkinson’s was founded by four people living with Parkinson’s who felt that nobody was taking a cure seriously enough and that there was an urgent need for a focused approach to curative research...
Learn more
Win a framed silkscreen print by acclaimed Cure³ artist Bruce McLean!
Our latest exciting raffle for aa framed silkscreen print by acclaimed Cure³ artist Bruce McLean raised over £1600 for our research. Thank you! Read on to find out more about the raffle below. ‘A Vase of Arranged Flowers in a Wild Garden – Yellow’ and ‘A…
Ozzy Osbourne and Black Sabbath announce farewell concert supporting three charities… including Cure Parkinson’s!
We are delighted to be a beneficiary of Black Sabbath’s Back to the Beginning show, held on 5 July at Villa Park. The farewell gig will see the original members of Black Sabbath – consisting of Ozzy Osbourne, Tony Iommi, Geezer Butler and Bill Ward…
Exenatide-PD3 results published
The full results of the Exenatide-PD3 study, a phase 3 clinical trial of Type 2 diabetes drug exenatide (Bydureon), have now been published. They report that the study unfortunately did not meet its primary or secondary endpoints. The full results of the Exenatide-PD3 study have…
Remembering a loved one with in memory giving
Honouring a loved one’s memory through charitable giving is a deeply meaningful way to celebrate their life and make a lasting difference. In memory donations not only pay tribute to someone special but also provide crucial support for our work to find a cure for…
Prioritising the most promising drugs for Parkinson’s: our new drug screening project
Cure Parkinson’s is excited to announce funding for a preclinical project that aims to test, evaluate and compare drugs that have the potential to slow Parkinson’s progression. Established by Cure Parkinson’s, in collaboration with Van Andel Institute (VAI), the International Linked Clinical Trials (iLCT) committee…